Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin

被引：0
|
作者：
Sakurai, R. [1 ]
Kaira, K. [2 ]
Miura, Y. [1 ]
Tomizawa, Y. [3 ]
Tsukagoshi, Y. [1 ]
Masuda, T. [1 ]
Kasahara, N. [1 ]
Sunaga, N. [4 ]
Saito, R. [3 ]
Hisada, T. [1 ]
机构：
[1] Gunma Univ Hosp, Div Allergy & Resp Med, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma, Japan
[3] Natl Hosp Org Shibukawa Med Ctr, Div Resp Med, Shibukawa, Japan
[4] Gunma Univ Hosp, Oncol Ctr, Maebashi, Gunma, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
topoisomerase-II; Amrubicin; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-027
引用
收藏
页码：S2078 / S2078
页数：1
相关论文
共 50 条
  • [1] Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin
    Sakurai, Reiko
    Kaira, Kyoichi
    Miura, Yosuke
    Sunaga, Noriaki
    Saito, Ryusei
    Oyama, Tetsunari
    Hisada, Takeshi
    Yamada, Masanobu
    THORACIC CANCER, 2020, 11 (02) : 426 - 435
  • [2] Clinical Significance of Topoisomerase-II Expression in Patients with Relapsed HGNEC of the Lung Treated with Amrubicin
    Miura, Y.
    Kaira, K.
    Sakurai, R.
    Tomizawa, Y.
    Tsukagoshi, Y.
    Masuda, T.
    Kasahara, N.
    Sunaga, N.
    Saito, R.
    Hisada, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2189 - S2189
  • [3] High expression of topoisomerase-II predicts favorable clinical outcomes in patients with relapsed small cell lung cancers receiving amrubicin
    Miura, Yosuke
    Kaira, Kyoichi
    Sakurai, Reiko
    Sunaga, Noriaki
    Saito, Ryusei
    Hisada, Takeshi
    Yamada, Masanobu
    LUNG CANCER, 2018, 115 : 42 - 48
  • [4] The prognostic value of the expression of topoisomerase-II alpha in non-small lung carcinoma treated by radiotherapy
    Langendijk, JA
    Thunnissen, FBJM
    Lamers, RJS
    deJong, JMA
    tenVelde, GPM
    Guinee, DG
    Holden, J
    Arends, JW
    Wouters, EFM
    LABORATORY INVESTIGATION, 1997, 76 (01) : 978 - 978
  • [5] Clinical significance of annexin II expression in human non-small cell lung cancer
    Jia, Jin-Wei
    Li, Kun-Lin
    Wu, Jin-Xing
    Guo, Shu-Liang
    TUMOR BIOLOGY, 2013, 34 (03) : 1767 - 1771
  • [6] Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
    Shigematsu, Yoshiki
    Hanagiri, Takeshi
    Shiota, Hironobu
    Kuroda, Koji
    Baba, Tetsuro
    Mizukami, Makiko
    So, Tetsuya
    Ichiki, Yoshinobu
    Yasuda, Manabu
    So, Tomoko
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    LUNG CANCER, 2010, 68 (01) : 105 - 110
  • [7] Clinical Significance of Expression of Periostin in Non-small Cell Lung Cancer
    Qiao, Zhixiong
    Zhang, Lan
    He, Jinxi
    He, Wei
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (09): : 1149 - 1153
  • [8] EXPRESSION AND CLINICAL SIGNIFICANCE OF CN- II IN NON-SMALL CELL LUNG CANCER TISSUES
    Qu, Li L.
    Liu, Qing X.
    Gao, Jun H.
    Qin, Feng H.
    Li, Jie J.
    Guo, Feng W.
    Wang, Xia W.
    Tang, Hao C.
    Li, Yan X.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S459 - S459
  • [9] Differential expression of DNA topoisomerase IIα and IIβ genes between small cell and non-small cell lung cancer
    Syahruddin, E
    Oguri, T
    Takahashi, T
    Isobe, T
    Fujiwara, Y
    Yamakido, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1998, 89 (08): : 855 - 861
  • [10] The clinical significance of autophagy in patients with non-small cell lung cancer
    Nakashima, Nariyasu
    Liu, Dage
    Nakano, Takayuki
    Go, Tetsuhiko
    Yokomise, Hiroyasu
    CANCER SCIENCE, 2018, 109 : 1425 - 1425
12345